Navigation Links
deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
Date:6/29/2009

eutically to address this risk. As ever, deCODEme subscribers will see this new variant in their profiles, and we look forward building on this discovery," said Kari Stefansson, CEO of deCODE.

About kidney stones

Kidney stones are small crystals formed of dissolved minerals, mainly calcium, that form in the kidneys. Smaller stones can simply be passed through urination, though larger ones can block the urinary tract, causing considerable pain and bleeding. Kidney stones affect some 5% of women and 10% of men in the industrialized world. Larger stones can be detected with ultrasound screening and broken up to facilitate passage, though the recurrence rate is high.

deCODE would like to thank all those who participated in this study, as well as the collaborating clinicians and scientists from the Landspitali University Hospital in Reykjavik, Iceland; Radboud University Nijmegen Medical Centre in Nijmegen, Netherlands; Nordic Bioscience A/S in Herlev, Denmark; and the Center for Clinical and Basic Research A/S in Ballerup, Denmark.

About deCODE

deCODE is a bio-pharmaceutical company developing drugs and DNA-based tests to improve the treatment, diagnosis and prevention of common diseases. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader in human genetics, and has identified key variations in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE has brought to market a growing range
'/>"/>

SOURCE deCODE genetics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. deCODE Reinstated to Nasdaq Global Market
2. deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
3. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
4. deCODE genetics Announces First Quarter 2009 Financial Results
5. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
6. Nasdaq Stays Suspension of Trading in deCODE Stock
7. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
8. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
9. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
10. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
11. deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
(Date:6/1/2015)... and YONGIN, South Korea , ... pride that Green Cross Biotherapeutics Inc. (GCBT) kicked off ... located on the Montreal Technoparc,s Saint-Laurent Campus. The CA$315 ... investment projects in Canada in ... the first intravenous immunoglobulin (IVIG) and albumin manufacturing plant ...
(Date:6/1/2015)... GenomeDx Biosciences today announced that ... classified various subtypes of bladder cancer based ... including one type associated with resistance to ... has potential as a tool to predict ... with muscle-invasive bladder cancers (MIBC). The study ...
(Date:6/1/2015)... ON , June 1, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... period ended March 31, 2015.  Biorem,s complete 2015 first quarter financial ... Financial Summary:Three-months ended March 31,(in CDN$,000 except ... , 4,689 , 1,974 Gross profit , ... (318) Net earnings (loss) , 528 , ...
Breaking Biology Technology:Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3
... Calif., April 16 Cord Blood America, Inc. (OTC ... preservation company ( http://www.cordblood-america.com ) ... cells to families nationwide and internationally, said today that ... business increased 8.7 percent, or $0.3 million, to $3.4 ...
... of drug safety services to the life sciences industry, has appointed Charles ... Saldarini is a proven leader in the field of biopharmaceutical outsourcing services. ... of CEO as he established the company as the leader in contract ... ...
... -- China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company producing over-the-counter,drugs in the People,s ... a conference call at 10:00 a.m. Eastern Daylight Time ... quarter and fiscal year 2008,financial results. , ...
Cached Biology Technology:Cord Blood America Announces 2008 Financial Results 2Charles Saldarini is New CEO of Sentrx 2Charles Saldarini is New CEO of Sentrx 3China Sky One Medical, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Results 2
(Date:5/11/2015)... May 11, 2015  Through a well-rounded UAS delegation representing ... had a strong showing at AUVSI,s Unmanned 2015 conference last ... Ohio,s UAS industry met with over ... all points along the UAS ecosystem. "Our ... Vice President for Aerospace Rich Knoll . "If you ...
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a developer ... helmet producer, announced today that they will expand their ... world,s first bio-sensing cycling helmet and the first joint ... two new colors in order to give cyclists more ... In addition, LifeBEAM and Lazer announced their plan to ...
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
... Western Reserve School of Medicine have discovered a technique ... brain cells destroyed in patients with multiple sclerosis, cerebral ... This discovery appears today in the journal Nature ... production of myelinating cells, which provide a vital sheath ...
... N.J.The State of Spinal Cord Injury: Latest News on ... be held on Wednesday, April 17, 2013, from 4:30 ... Way, West Orange, N.J. This special Grand Rounds is ... System (NNJSCIS) and the Spinal Cord Injury Project of ...
... (Philadelphia, PA) A major factor in the advance of ... that a team of scientists at Temple University School of ... with new medicines. Now, the researchers are one step closer ... key molecule in an unexpected place in heart cells ...
Cached Biology News:Ordinary skin cells morphed into functional brain cells 2The State of Spinal Cord Injury Grand Rounds 2Clues to heart disease in unexpected places, Temple researchers discover 2Clues to heart disease in unexpected places, Temple researchers discover 3
... the following: , Coated Capture Antibody: 12 x ... Diluent: 300 mL of 2X concentrate , ... lyophilized peptide , Lyophilized Standard Diluent: 3 mL ... , Secondary Antibody-HRP: 30 microL of concentrate , ...
...
Human Cell Line Slides...
... ZMD.471. Immunogen: Synthetic peptide derived ... mouse junctophilin-1. Specificity: Specific for ... (positive controls: mouse brain and skeletal ... skeletal muscle tissues). Applications: Western ...
Biology Products: